Drug Offers New Hope to Select Patients with ALS, UCSF-CPMC Study Shows
A UCSF-led study found a new drug for ALS that shows to slow or temporarily stall the progression of ALS in a select group of patients, with three times as many patients' disease slowing compared to those who received a placebo.
![Microscopic image of a macrophage immunce cell](/sites/default/files/styles/news_card__image/public/2022-01/macrophage-immune-cell.jpg)